Dive into a captivating session that explores complex anatomical features in interventional cardiology. Discover dynamic improvements in tricuspid valve coaptation and regurgitation post-TAVI, the overlooked threat of aortic stenosis hidden by mitral stenosis, marked improvement in left ventricular function after simultaneous TAVI and M-TEER, recognition of...

Delve into this captivating session that explores challenging TAVI procedures. Witness the management of a patient with pure aortic regurgitation and previous mitral valve replacement, an extremely challenging transfemoral TAVI, the management of bradycardia before TAVI in a patient with MVR and TVR, a case of...

Delve into the second part of the TAV-in-SAV session, where you'll discover the reproducible BASILICA technique using an enface view, chimney stenting during TAV-in-SAV in a high coronary occlusion risk patient, urgent zero contrast TAV-in-SAV, a tale of a complication where you shouldn't BASILICA the new...

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools,...

Previous comparisons between AMPLATZER septal occluders and other designs were retrospective, non-randomised, non-concurrent and involved fewer patients... A prospective concurrent head-to-head comparison of AMPLATZER (ASO), Cera (CSO) and Figulla (FSO) septal occluders was planned to study the patient outcomes.

Alex Sticchi provides his take on the TRILUMINATE pivotal trial which was presented by David H. Adams at the TCT Congress 2022.

A record 12,100 participants from 130 countries have just taken part in the highly educational WorldLeading Course in interventional cardiovascular medicine. They enjoyed a unique opportunity to exchange their knowledge, skills and experience on a global scale.

Paris – France, 17 May 2024. As always, the thought-provoking...

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

EuroPCR, the annual world-leading Course in interventional cardiovascular medicine, has been taking place for over 30 years. It is tailored for all those dedicated to the sharing of knowledge and skills, and improvement of patient care worldwide: interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied...

Charles Fauvel provides his take on the RELIEVE-HF study outcomes presented by Gregg W. Stone at ACC.24 in Atlanta.

Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).

Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Kalaivani Mahadevan and Sofia Papadopoulou provide their take on the INVEST CTO trial, presented by Anja Oksnes at TCT 2025, in San Francisco.